
USFDA APPLICATION NUMBER - 205122 / DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 150MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| TOPIRAMATE(UNII: 0H73WJJ391) (TOPIRAMATE - UNII:0H73WJJ391) | TOPIRAMATE | 100mg |
Inactive Ingredients
| Ingredient Name | Glenmark Pharmaceuticals Inc., USA | NorthStar RxLLC | REMEDYREPACK INC. |
|---|---|---|---|
| AMMONIA(5138Q19F1X) | |||
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |||
| D&C RED NO. 30(2S42T2808B) | |||
| DIETHYL PHTHALATE(UF064M00AF) | |||
| ETHYLCELLULOSE (10 MPA.S)(3DYK7UYZ62) | |||
| FD&C RED NO. 40(WZB9127XOA) | |||
| FD&C YELLOW NO. 5(I753WB2F1M) | |||
| FERRIC OXIDE RED(1K09F3G675) | |||
| FERRIC OXIDE YELLOW(EX438O2MRT) | |||
| FERROSOFERRIC OXIDE(XM0M87F357) | |||
| HYPROMELLOSE 2910 (5 MPA.S)(R75537T0T4) | |||
| HYPROMELLOSE 2910 (6 MPA.S)(0WZ8WG20P6) | |||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |||
| POLYETHYLENE GLYCOL 6000(30IQX730WE) | |||
| POTASSIUM HYDROXIDE(WZH3C48M4T) | |||
| PROPYLENE GLYCOL(6DC9Q167V3) | |||
| SHELLAC(46N107B71O) | |||
| TALC(7SEV7J4R1U) | |||
| TITANIUM DIOXIDE(15FIX9V2JP) |